FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895822497> ?p ?o ?g. }

• W2895822497 endingPage "110" @default.
• W2895822497 startingPage "103" @default.
• W2895822497 abstract "Seizure is the most common signs of nervous system disease in neonates. The first line of treatments in neonatal seizures (after ruling out and emergency treatment of electrolyte imbalance and hypoglycemia) are phenobarbital and phenytoin. We aimed to evaluate drugs that are more effective on neonatal seizure.Patients admitted to neonatal wards & NICUs (level IIa& IIb) in Qom hospitals (2015-2017), central Iran with presentation of seizure, were enrolled in this clinical trial study. After ruling out electrolyte imbalance and hypoglycemia these neonates were managed by intravenous phenobarbital, then if no response was seen we added intravenous phenytoin and for remaining neonates with refractory seizure we applied oral levetiracetam as add on therapy. The study was registered as code number of IRCT2016051527896N1.Initially, 245 neonates were enrolled. According to exclusion criteria, 12 cases were excluded, and phenobarbital was prescribed to the remaining patients. Out of these, 86 patients did not respond, and phenytoin was prescribed for them. Forty two patients who were not responding to phenytoin were finally treated with oral levetiracetam. Finally, 95.3% of seizures were controlled with oral levetiracetam but 4.7% were not cured.When the intravenous form of levetiracetam is not available and neonatal seizure does not respond to first line classic drugs, oral levetiracetam as add on therapy maybe effective." @default.
• W2895822497 created "2018-10-26" @default.
• W2895822497 creator A5000180949 @default.
• W2895822497 creator A5018856133 @default.
• W2895822497 creator A5032450499 @default.
• W2895822497 creator A5045901150 @default.
• W2895822497 creator A5076456487 @default.
• W2895822497 date "2018-01-01" @default.
• W2895822497 modified "2023-09-23" @default.
• W2895822497 title "Oral Levetiracetam as Add-On Therapy in Refractory Neonatal Seizures." @default.
• W2895822497 cites W1498284854 @default.
• W2895822497 cites W1778451239 @default.
• W2895822497 cites W1964974176 @default.
• W2895822497 cites W1983021107 @default.
• W2895822497 cites W1988414223 @default.
• W2895822497 cites W1993913390 @default.
• W2895822497 cites W2016908171 @default.
• W2895822497 cites W2024970250 @default.
• W2895822497 cites W2026483359 @default.
• W2895822497 cites W2031118854 @default.
• W2895822497 cites W2034709361 @default.
• W2895822497 cites W2036467957 @default.
• W2895822497 cites W2060006415 @default.
• W2895822497 cites W2103248381 @default.
• W2895822497 cites W2132282183 @default.
• W2895822497 cites W2132403112 @default.
• W2895822497 cites W2145006863 @default.
• W2895822497 cites W2167930657 @default.
• W2895822497 cites W2168463219 @default.
• W2895822497 cites W2460467431 @default.
• W2895822497 cites W4239594659 @default.
• W2895822497 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6160636" @default.
• W2895822497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30279713" @default.
• W2895822497 hasPublicationYear "2018" @default.
• W2895822497 type Work @default.
• W2895822497 sameAs 2895822497 @default.
• W2895822497 citedByCount "1" @default.
• W2895822497 countsByYear W28958224972023 @default.
• W2895822497 crossrefType "journal-article" @default.
• W2895822497 hasAuthorship W2895822497A5000180949 @default.
• W2895822497 hasAuthorship W2895822497A5018856133 @default.
• W2895822497 hasAuthorship W2895822497A5032450499 @default.
• W2895822497 hasAuthorship W2895822497A5045901150 @default.
• W2895822497 hasAuthorship W2895822497A5076456487 @default.
• W2895822497 hasConcept C118552586 @default.
• W2895822497 hasConcept C121332964 @default.
• W2895822497 hasConcept C126322002 @default.
• W2895822497 hasConcept C142424586 @default.
• W2895822497 hasConcept C187212893 @default.
• W2895822497 hasConcept C2777010014 @default.
• W2895822497 hasConcept C2777332695 @default.
• W2895822497 hasConcept C2777341932 @default.
• W2895822497 hasConcept C2778186239 @default.
• W2895822497 hasConcept C2778337148 @default.
• W2895822497 hasConcept C2778793413 @default.
• W2895822497 hasConcept C2779306644 @default.
• W2895822497 hasConcept C2780208886 @default.
• W2895822497 hasConcept C2780668416 @default.
• W2895822497 hasConcept C42219234 @default.
• W2895822497 hasConcept C71924100 @default.
• W2895822497 hasConcept C87355193 @default.
• W2895822497 hasConcept C98274493 @default.
• W2895822497 hasConceptScore W2895822497C118552586 @default.
• W2895822497 hasConceptScore W2895822497C121332964 @default.
• W2895822497 hasConceptScore W2895822497C126322002 @default.
• W2895822497 hasConceptScore W2895822497C142424586 @default.
• W2895822497 hasConceptScore W2895822497C187212893 @default.
• W2895822497 hasConceptScore W2895822497C2777010014 @default.
• W2895822497 hasConceptScore W2895822497C2777332695 @default.
• W2895822497 hasConceptScore W2895822497C2777341932 @default.
• W2895822497 hasConceptScore W2895822497C2778186239 @default.
• W2895822497 hasConceptScore W2895822497C2778337148 @default.
• W2895822497 hasConceptScore W2895822497C2778793413 @default.
• W2895822497 hasConceptScore W2895822497C2779306644 @default.
• W2895822497 hasConceptScore W2895822497C2780208886 @default.
• W2895822497 hasConceptScore W2895822497C2780668416 @default.
• W2895822497 hasConceptScore W2895822497C42219234 @default.
• W2895822497 hasConceptScore W2895822497C71924100 @default.
• W2895822497 hasConceptScore W2895822497C87355193 @default.
• W2895822497 hasConceptScore W2895822497C98274493 @default.
• W2895822497 hasIssue "4" @default.
• W2895822497 hasLocation W28958224971 @default.
• W2895822497 hasOpenAccess W2895822497 @default.
• W2895822497 hasPrimaryLocation W28958224971 @default.
• W2895822497 hasRelatedWork W2063348129 @default.
• W2895822497 hasRelatedWork W2142890988 @default.
• W2895822497 hasRelatedWork W2162284004 @default.
• W2895822497 hasRelatedWork W2167930657 @default.
• W2895822497 hasRelatedWork W2292258666 @default.
• W2895822497 hasRelatedWork W2331889928 @default.
• W2895822497 hasRelatedWork W2413433073 @default.
• W2895822497 hasRelatedWork W2438547038 @default.
• W2895822497 hasRelatedWork W2546790806 @default.
• W2895822497 hasRelatedWork W2740870090 @default.
• W2895822497 hasRelatedWork W2786674817 @default.
• W2895822497 hasRelatedWork W2803143191 @default.
• W2895822497 hasRelatedWork W2951825726 @default.
• W2895822497 hasRelatedWork W2980893532 @default.

• next